1. Effect of catechin and commercial preparation of green tea essence on the pharmacokinetics of l‐dopa in rabbits.
- Author
-
Lin, Shwu‐Jiuan, Tai, Lily, Huang, Yu‐Jie, Uang, Yow‐Shieng, Ho, Yih, Hsu, Kuang‐Yang, and Wang, Li‐Hsuan
- Abstract
The aim of this study was to investigate drug interactions of L‐dopa/carbidopa with catechin and green tea essence in rabbits following the simultaneous administration via an intramuscular injection of catechin or via an intragastric route for green tea essence with L‐dopa/carbidopa. The results indicated that catechin at doses of 10, 20 and 50 mg/kg increased the area under the plasma concentration–time curve from time zero to the time of the last quantifiable concentration (AUC0–t) of L‐dopa by about 69, 78 and 42%, respectively. The metabolic ratios of the AUC0–t for 3‐O‐methyldopa (3‐OMD)/L‐dopa significantly decreased by about 56, 68 and 76% (P < 0.05), respectively. In addition, a single dose of 5/1.25 mg/kg L‐dopa/carbidopa was co‐administrated with 150 mg/kg green tea essence via an intragastric route with an oral‐gastric tube. Comparing the related pharmacokinetic parameters of L‐dopa, the clearance and metabolic ratio of L‐dopa decreased by 20 and 19% (P < 0.05), respectively. In conclusion, catechin and green tea essence can significantly affect the metabolism of L‐dopa by the catechol‐O‐methyltransferase (COMT) metabolic pathway. Catechin can enhance L‐dopa bioavailability, and both catechin and green tea essence decreased 3‐OMD formation. Therefore, catechin and green tea essence may increase L‐dopa efficacy for Parkinson's disease treatment. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF